162 related articles for article (PubMed ID: 35646818)
1. Corrigendum: Nano-Theranostics for the Sensing, Imaging and Therapy of Prostate Cancers.
Calatayud DG; Neophytou S; Nicodemou E; Giuffrida SG; Ge H; Pascu SI
Front Chem; 2022; 10():919505. PubMed ID: 35646818
[TBL] [Abstract][Full Text] [Related]
2. Nano-Theranostics for the Sensing, Imaging and Therapy of Prostate Cancers.
Calatayud DG; Neophytou S; Nicodemou E; Giuffrida SG; Ge H; Pascu SI
Front Chem; 2022; 10():830133. PubMed ID: 35494646
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum: Oxygen Sensing, Hypoxia Tracing and
Mirabello V; Cortezon-Tamarit F; Pascu SI
Front Chem; 2018; 6():512. PubMed ID: 30386776
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum: Programmable Ce6 Delivery via Cyclopamine Based Tumor Microenvironment Modulating Nano-System for Enhanced Photodynamic Therapy in Breast Cancer.
Feng C; Chen L; Lu Y; Liu J; Liang S; Lin Y; Li Y; Dong C
Front Chem; 2020; 8():608312. PubMed ID: 33330403
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum: The development of microscopic imaging technology and its application in micro-and nanotechnology.
Wang Y; Zhang X; Xu J; Sun X; Zhao X; Li H; Liu Y; Tian J; Hao X; Kong X; Wang Z; Yang J; Su Y
Front Chem; 2023; 11():1351941. PubMed ID: 38156022
[TBL] [Abstract][Full Text] [Related]
6. Bioresponsive Nanomedicine: The Next Step of Deadliest Cancers' Theranostics.
Mao Y; Liu X
Front Chem; 2020; 8():257. PubMed ID: 32328480
[TBL] [Abstract][Full Text] [Related]
7. Corrigendum: The development and progression of micro-nano optics.
Wang Y; Yang J; Wang Z; Kong X; Sun X; Tian J; Zhang X; Zhao X; Liu Y; Li H; Su Y; Hao X; Xu J
Front Chem; 2023; 11():1351934. PubMed ID: 38162393
[TBL] [Abstract][Full Text] [Related]
8. Corrigendum: Micro-Nano Bioactive Glass Particles Incorporated Porous Scaffold for Promoting Osteogenesis and Angiogenesis
Tian T; Xie W; Gao W; Wang G; Zeng L; Miao G; Lei B; Lin Z; Chen X
Front Chem; 2022; 10():891108. PubMed ID: 35559225
[TBL] [Abstract][Full Text] [Related]
9. Theranostic Pretargeting Drug Delivery and Imaging Platforms in Cancer Precision Medicine.
Hapuarachchige S; Artemov D
Front Oncol; 2020; 10():1131. PubMed ID: 32793481
[TBL] [Abstract][Full Text] [Related]
10. Changing the Goal Posts: Prostate-specific Membrane Antigen Targeted Theranostics in Prostate Cancer.
Emmett L
Semin Oncol Nurs; 2020 Aug; 36(4):151052. PubMed ID: 32674976
[TBL] [Abstract][Full Text] [Related]
11. Corrigendum: Design, Synthesis, and Biological Evaluation of (E)-N'-((1-Chloro-3,4-Dihydronaphthalen-2-yl)Methylene)Benzohydrazide Derivatives as Anti-prostate Cancer Agents.
Arjun HA; Elancheran R; Manikandan N; Lakshmithendral K; Ramanathan M; Bhattacharjee A; Lokanath NK; Kabilan S
Front Chem; 2019; 7():804. PubMed ID: 31840023
[TBL] [Abstract][Full Text] [Related]
12. Corrigendum: New Sesquiterpenoids From Plant-Associated
Luo HZ; Jiang H; Huang XS; Jia AQ
Front Chem; 2022; 10():946835. PubMed ID: 35815215
[TBL] [Abstract][Full Text] [Related]
13. Corrigendum: Highly Ordered Mesoporous NiCo
Ren Q; Wu G; Xing W; Han J; Li P; Li B; Cheng J; Wu S; Zou R; Hu J
Front Chem; 2019; 7():600. PubMed ID: 31555640
[TBL] [Abstract][Full Text] [Related]
14. Corrigendum: A Saccharide Chemosensor Array Developed Based on an Indicator Displacement Assay Using a Combination of Commercially Available Reagents.
Sasaki Y; Zhang Z; Minami T
Front Chem; 2019; 7():150. PubMed ID: 30968016
[TBL] [Abstract][Full Text] [Related]
15. Corrigendum: Yolk@Wrinkled-double shell smart nanoreactors: new platforms for mineralization of pharmaceutical wastewater.
Habibi Zare M; Mehrabani-Zeinabad A
Front Chem; 2024; 12():1385825. PubMed ID: 38510814
[TBL] [Abstract][Full Text] [Related]
16. Corrigendum: Progress of photoacoustic imaging combined with targeted photoacoustic contrast agents in tumor molecular imaging.
Zheng Y; Liu M; Jiang L
Front Chem; 2022; 10():1121672. PubMed ID: 36618866
[TBL] [Abstract][Full Text] [Related]
17. Corrigendum: Super-Resolution Microscopy: Shedding New Light on
Jing Y; Zhang C; Yu B; Lin D; Qu J
Front Chem; 2021; 9():795767. PubMed ID: 34881228
[TBL] [Abstract][Full Text] [Related]
18. Corrigendum: Rational design of a Gd(III)-Cu(II) nanobooster for chemodynamic therapy against cancer cells.
Shi XY; Shen TX; Zhang AL; Tan LT; Shen WC; Zhong HJ; Zhang SL; Gu YL; Shen L
Front Chem; 2022; 10():1075376. PubMed ID: 36482938
[TBL] [Abstract][Full Text] [Related]
19. Ultrasound-based nanomedicine for molecular imaging of prostate cancer: from diagnostics to theranostics.
Zhu Y; Sun Y; Duan Y; Chen Y
Nanomedicine (Lond); 2021 Oct; 16(23):2029-2032. PubMed ID: 34519535
[No Abstract] [Full Text] [Related]
20. Corrigendum: High-Sensitive Surface Plasmon Resonance Imaging Biosensor Based on Dual-Wavelength Differential Method.
Zeng Y; Zhou J; Sang W; Kong W; Qu J; Ho HP; Zhou K; Gao BZ; Chen J; Shao Y
Front Chem; 2022; 10():849460. PubMed ID: 35281560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
